Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nintedanib”

198 trials

Showing 20 of 198 results

Early research (Phase 1)Study completedNCT02225405
What this trial is testing

Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer

Who this might be right for
Stage IB Non-Small Cell Lung Carcinoma AJCC v7Stage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7+2 more
M.D. Anderson Cancer Center 26
Early research (Phase 1)Study completedNCT04938453
What this trial is testing

A Study in Healthy Men to Test Whether Four Capsules of 25 mg Nintedanib Are Taken up in the Body in the Same Way as One 100 mg Capsule

Who this might be right for
Healthy
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT01417156
What this trial is testing

Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)

Who this might be right for
Pulmonary Fibrosis
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT00904839
What this trial is testing

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 128
Early research (Phase 1)Study completedNCT07229716
What this trial is testing

Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects

Who this might be right for
Pulmonary Fibrosis
Guangdong Hengrui Pharmaceutical Co., Ltd 20
Large-scale testing (Phase 3)Study completedNCT01619085
What this trial is testing

Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 752
Early research (Phase 1)Study completedNCT01594125
What this trial is testing

Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Boehringer Ingelheim 30
Testing effectiveness (Phase 2)Study completedNCT01788982
What this trial is testing

Nintedanib(BIBF1120) in Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Differentiated Thyroid Cancer (DTC)
European Organisation for Research and Treatment of Cancer - EORTC 100
Early research (Phase 1)Ended earlyNCT02751385
What this trial is testing

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 2
Post-approval studies (Phase 4)Study completedNCT02788474
What this trial is testing

Effect of Nintedanib on Biomarkers of Extracellular Matrix Turnover in Patients With Idiopathic Pulmonary Fibrosis and Limited Forced Vital Capacity Impairment

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 347
Testing effectiveness (Phase 2)Ended earlyNCT02902484
What this trial is testing

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Cancer of Pancreas
University of Texas Southwestern Medical Center 14
Early research (Phase 1)Study completedNCT05262751
What this trial is testing

A Study in Healthy Men to Find the Best Formulation for Once Daily Intake of Nintedanib

Who this might be right for
Healthy
Boehringer Ingelheim 21
Not applicableStudy completedNCT02671422
What this trial is testing

LUME BioNIS: a Biomarker Study in Patients With NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 260
Early research (Phase 1)Ended earlyNCT01548924
What this trial is testing

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Early research (Phase 1)Study completedNCT01679613
What this trial is testing

Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 34
Early research (Phase 1)Study completedNCT00876460
What this trial is testing

BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 43
Early research (Phase 1)Study completedNCT02182219
What this trial is testing

Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT02234596
What this trial is testing

Nintedanib in Patients With Advanced Esophagogastric Cancer

Who this might be right for
Esophagogastric Adenocarcinoma
Memorial Sloan Kettering Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT03313180
What this trial is testing

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim 444
Early research (Phase 1)Ended earlyNCT01485874
What this trial is testing

Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hoosier Cancer Research Network 11
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation